Clinical Trials Directory

Trials / Sponsors / POZEN

POZEN

Industry · 27 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA325
Platelet Aggregation
Phase 12010-11-01
CompletedStudy to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated
Gastric Ulcer
Phase 32009-10-01
CompletedA Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coat
Gastric Ulcer
Phase 32009-10-01
CompletedStudy to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associate
Aspirin-Associated Gastric Ulcers
Phase 32009-10-01
CompletedA Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels
Arthritis
Phase 12008-08-01
CompletedPhase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib
Healthy Volunteer
Phase 12008-07-01
CompletedStudy Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations
Arthritis
Phase 12008-06-01
CompletedStudy Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celec
Healthy
Phase 12008-06-01
CompletedStudy Evaluating the Effect of Food on the Bioavailability of PN400 Components
Arthritis
Phase 12008-05-01
CompletedEfficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis
Osteoarthritis
Phase 32008-04-01
CompletedEfficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis
Osteoarthritis
Phase 32008-04-01
CompletedStudy Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations
Arthritis
Phase 12008-03-01
CompletedEvaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy
Healthy
Phase 12008-02-01
CompletedPK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400
Healthy
Phase 12008-01-01
CompletedEvaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID)
Gastric Ulcer
Phase 32007-09-01
CompletedEvaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID)
Gastric Ulcer
Phase 32007-09-01
TerminatedEvaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec
Gastric Ulcer
Phase 32007-09-01
CompletedA 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)
Gastric Ulcer
Phase 32007-03-01
CompletedA Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin
Healthy
Phase 12007-02-01
CompletedAn Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour In
Healthy
Phase 12007-01-01
CompletedTo Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus Enteric-Coated Aspirin
Healthy
Phase 12006-11-01
CompletedStudy to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Sub
Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis
Phase 32006-09-01
CompletedStudy of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.
Headache (Migraine)
Phase 22005-12-01
CompletedStudy of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy
Bunionectomy, Orthopedic Surgery
Phase 22005-11-01
CompletedTo Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches
Migraine Headaches
Phase 32004-08-01
CompletedTo Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches
Migraine Headaches
Phase 32004-07-01
CompletedThe Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months
Migraine Headaches
Phase 32004-05-01